Related Experiment Video

Updated: Mar 27, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K

Updates in Therapy for Advanced Melanoma

Bhavana P Singh1, April K S Salama2

  • 1Department of Internal Medicine, Duke University Medical Center, Durham, NC 27710, USA. bhavana.pendurthi@dm.duke.edu.

Cancers
|January 20, 2016
PubMed

Insights

Systemic therapy for cutaneous melanoma has advanced with targeted treatments like BRAF inhibitors and immune checkpoint inhibitors (CTLA-4, PD-1/PD-L1), improving patient outcomes.

Area of Science:

  • Oncology
  • Dermatology
  • Immunotherapy

Background:

  • Cutaneous melanoma is an aggressive skin cancer linked to significant mortality.
  • Advances in understanding melanoma genetics and immunology have driven therapeutic progress.

Purpose of the Study:

  • To review current systemic therapies for cutaneous melanoma.
  • To discuss the benefits and limitations of existing treatments.
  • To explore future directions in melanoma treatment.

Main Methods:

  • Literature review of recent advancements in melanoma systemic therapy.
  • Analysis of targeted therapies and immunotherapies.
  • Discussion of clinical trial outcomes and emerging agents.

Main Results:

  • Targeted therapies, including BRAF inhibitors, offer personalized treatment options.
  • Immune checkpoint inhibitors (CTLA-4, PD-1/PD-L1) have transformed melanoma management.
  • Multiple novel agents are under investigation for melanoma treatment.

Conclusions:

  • Systemic therapy for melanoma is increasingly sophisticated and multifaceted.
  • Current treatments provide significant clinical benefit but have limitations.
  • Future research holds promise for further improving melanoma patient survival.
Keywords:
BRAFCTLA-4MEKPD-1immunotherapymelanomatargeted therapy

More Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

14.0K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K